You have 9 free searches left this month | for more free features.

BGB-3111

Showing 1 - 25 of 109

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

Not yet recruiting
  • CLL
  • (no location specified)
Oct 3, 2023

Lymphoma, Leukemia Trial in Australia, China (Zanubrutinib, Tislelizumab)

Completed
  • Lymphoma
  • Leukemia
  • Darlinghurst, New South Wales, Australia
  • +9 more
Mar 16, 2022

Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Jan 23, 2023

Relapsed/Refractory Marginal Zone Lymphoma Trial in Westbury (Zanubrutinib, Rituximab, Lenalidomide)

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Westbury, New York
    Clinical Research Alliance, Inc.
Nov 14, 2022

Richter Transformation Trial in Austria, Denmark, Germany (Tislelizumab, Zanubrutinib)

Recruiting
  • Richter Transformation
  • Vienna, Austria
  • +11 more
Mar 8, 2022

Waldenstrom Macroglobulinemia Trial (Zanubrutinib)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • (no location specified)
Nov 28, 2022

Waldenström's Macroglobulinemia (WM) Trial in China (Zanubrutinib)

Completed
  • Waldenström's Macroglobulinemia (WM)
  • Beijing, Beijing, China
  • +10 more
Mar 7, 2022

CNS Lymphoma Trial in Beijing (Zanubrutinib)

Recruiting
  • CNS Lymphoma
  • Beijing, Beijing, China
    Peking University People's Hospital
Aug 1, 2022

Healthy Volunteers Trial in Daytona Beach, Dallas (Zanubrutinib)

Recruiting
  • Healthy Volunteers
  • Daytona Beach, Florida
  • +1 more
Mar 15, 2023

Marginal Zone Lymphoma, Follicular Lymphoma, DLBCL Trial in China (Zanubrutinib, Rituximab)

Completed
  • Marginal Zone Lymphoma
  • +2 more
  • Harbin, Heilongjiang, China
  • +3 more
Oct 26, 2021

B-cell Lymphoma Trial in China (Zanubrutinib)

Completed
  • B-cell Lymphoma
  • Beijing, Beijing, China
  • +3 more
Sep 26, 2021

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Houston (Rituximab, Zanubrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Healthy Volunteers Trial in Daytona Beach, Dallas (Zanubrutinib)

Completed
  • Healthy Volunteers
  • Daytona Beach, Florida
  • +1 more
Jan 27, 2023

Lupus Nephritis Trial in Guangdong (Zanubrutinib, Placebo)

Recruiting
  • Lupus Nephritis
  • Guangdong, Guangzhou, China
    Guangdong General Hospital
Apr 19, 2022

Refractory Mantle Cell Lymphoma, Relapsed Mantle Cell Lymphoma Trial in China (Zanubrutinib)

Completed
  • Refractory Mantle Cell Lymphoma
  • Relapsed Mantle Cell Lymphoma
  • Beijing, Beijing, China
  • +13 more
Oct 8, 2021

Chronic Lymphoid Leukemia Trial in Germany (Bendamustine, Obinutuzumab, Zanubrutinib)

Recruiting
  • Chronic Lymphoid Leukemia
  • Aachen, Germany
  • +20 more
Oct 5, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Adelaide, Australia
  • +12 more
Jan 6, 2023

Diffuse Large B Cell Lymphoma Trial in Hangzhou (Rituximab, Lenalidomide, Zanubrutinib and RCHOP)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Rituximab, Lenalidomide, Zanubrutinib and RCHOP
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Mar 21, 2022

B-cell Malignancies Trial in Australia (Zanubrutinib, Fluconazole, Diltiazem)

Completed
  • B-cell Malignancies
  • Concord, New South Wales, Australia
  • +6 more
Jul 18, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Duarte (procedure, biological, drug)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Biospecimen Collection
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 30, 2023

Diffuse Large B-cell Lymphoma Trial in China (Zanubrutinib)

Completed
  • Diffuse Large B-cell Lymphoma
  • Beijing, Beijing, China
  • +10 more
Oct 11, 2021

Waldenström's Macroglobulinemia Trial in Worldwide (BGB-3111, Ibrutinib)

Completed
  • Waldenström's Macroglobulinemia
  • Phoenix, Arizona
  • +79 more
Jul 6, 2022

Healthy, Male Trial in Daytona Beach (Zanubrutinib, Rifabutin)

Completed
  • Healthy
  • Male
  • Daytona Beach, Florida
    Covance Clinical Research Unit
Aug 30, 2021